title: A new hope for patients suffering from multiple myeloma.
abstract: Multiple myeloma is a common hematological malignancy that leads to the occurrence of bone lesions. The combination of traditional cytotoxic and novel agents is usually taken to treat multiple myeloma-related bone diseases. However, the curative effect is not very satisfactory. Stem cell-based therapy has been recently introduced and investigated, which represents a new frontier in the treatment of multiple myeloma. In a recent interesting study, Dr Atsuta and colleagues provide a new insight into the effects of mesenchymal stem cells on multiple myeloma via Fas/Fas ligand pathway, which rekindles the fire of hope for those patients suffering from multiple myeloma.
authors.forename: Jinhua
authors.initials: J
authors.lastname: Yu
authors.forename: Yao
authors.initials: Y
authors.lastname: Li
mesh_terms: D000818:Animals; D053222:Fas Ligand Protein / Q000378:metabolism*; D005260:Female; D045164:Mesenchymal Stem Cell Transplantation; D059630:Mesenchymal Stem Cells / Q000166:cytology*; D009101:Multiple Myeloma / Q000601:surgery*; D019014:fas Receptor / Q000378:metabolism*
chemical_list: D053222:Fas Ligand Protein; D019014:fas Receptor